These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37194070)

  • 1. Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis.
    Li JM; Chang WH; Li L; Yang DC; Hsu SW; Kenyon NJ; Chen CH
    Respir Res; 2023 May; 24(1):132. PubMed ID: 37194070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targeting of argininosuccinate synthase 1 (ASS1)-deficient pulmonary fibrosis.
    Li JM; Yang DC; Oldham J; Linderholm A; Zhang J; Liu J; Kenyon NJ; Chen CH
    Mol Ther; 2021 Apr; 29(4):1487-1500. PubMed ID: 33508432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
    Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
    Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
    [No Abstract]   [Full Text] [Related]  

  • 4. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state.
    Caporarello N; Meridew JA; Jones DL; Tan Q; Haak AJ; Choi KM; Manlove LJ; Prakash YS; Tschumperlin DJ; Ligresti G
    Thorax; 2019 Aug; 74(8):749-760. PubMed ID: 31182654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis.
    Espindola MS; Habiel DM; Narayanan R; Jones I; Coelho AL; Murray LA; Jiang D; Noble PW; Hogaboam CM
    Am J Respir Crit Care Med; 2018 Jun; 197(11):1443-1456. PubMed ID: 29634284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic deficiency of the transcription factor NFAT1 confers protection against fibrogenic responses independent of immune influx.
    Vittal R; Walker NM; McLinden AP; Braeuer RR; Ke F; Fattahi F; Combs MP; Misumi K; Aoki Y; Wheeler DS; Wilke CA; Huang SK; Moore BB; Cao P; Lama VN
    Am J Physiol Lung Cell Mol Physiol; 2024 Jan; 326(1):L39-L51. PubMed ID: 37933452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Fas signaling in fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis.
    Redente EF; Chakraborty S; Sajuthi S; Black BP; Edelman BL; Seibold MA; Riches DW
    JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glutamine transporter ASCT2 mitigates bleomycin-induced pulmonary fibrosis in mice.
    Lian N; Jin H; Zhu W; Zhang C; Qi Y; Jiang M; Mao J; Lu X; Zhao F; Xi B; Qi X; Li Y
    Acta Histochem; 2022 Dec; 124(8):151961. PubMed ID: 36265204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1.
    Lino Cardenas CL; Henaoui IS; Courcot E; Roderburg C; Cauffiez C; Aubert S; Copin MC; Wallaert B; Glowacki F; Dewaeles E; Milosevic J; Maurizio J; Tedrow J; Marcet B; Lo-Guidice JM; Kaminski N; Barbry P; Luedde T; Perrais M; Mari B; Pottier N
    PLoS Genet; 2013; 9(2):e1003291. PubMed ID: 23459460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoid signalling/cannabinoid receptor 2 is involved in icariin-mediated protective effects against bleomycin-induced pulmonary fibrosis.
    Du W; Zhang T; Yang F; Gul A; Tang Z; Zhang H; Jiang S; Wang S; Dong J
    Phytomedicine; 2022 Aug; 103():154187. PubMed ID: 35667261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of siPTPN13 and siNOX4
    Hou J; Ji Q; Ji J; Ju S; Xu C; Yong X; Xu X; Muddassir M; Chen X; Xie J; Han X
    Theranostics; 2021; 11(7):3244-3261. PubMed ID: 33537085
    [No Abstract]   [Full Text] [Related]  

  • 14. YAP1/Twist promotes fibroblast activation and lung fibrosis that conferred by miR-15a loss in IPF.
    Chen Y; Zhao X; Sun J; Su W; Zhang L; Li Y; Liu Y; Zhang L; Lu Y; Shan H; Liang H
    Cell Death Differ; 2019 Sep; 26(9):1832-1844. PubMed ID: 30644438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Klotho antagonizes pulmonary fibrosis through suppressing pulmonary fibroblasts activation, migration, and extracellular matrix production: a therapeutic implication for idiopathic pulmonary fibrosis.
    Huang Q; Chen Y; Shen S; Wang Y; Liu L; Wu S; Xu W; Zhao W; Lin M; Wu J
    Aging (Albany NY); 2020 Apr; 12(7):5812-5831. PubMed ID: 32244228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IL-33:ST2 axis is unlikely to play a central fibrogenic role in idiopathic pulmonary fibrosis.
    Stephenson KE; Porte J; Kelly A; Wallace WA; Huntington CE; Overed-Sayer CL; Cohen ES; Jenkins RG; John AE
    Respir Res; 2023 Mar; 24(1):89. PubMed ID: 36949463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation.
    Liu P; Miao K; Zhang L; Mou Y; Xu Y; Xiong W; Yu J; Wang Y
    Respir Res; 2020 Feb; 21(1):58. PubMed ID: 32075634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin Enhances Ligand-induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo.
    Hohmann MS; Habiel DM; Coelho AL; Verri WA; Hogaboam CM
    Am J Respir Cell Mol Biol; 2019 Jan; 60(1):28-40. PubMed ID: 30109946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury.
    Smith MR; Gangireddy SR; Narala VR; Hogaboam CM; Standiford TJ; Christensen PJ; Kondapi AK; Reddy RC
    Am J Physiol Lung Cell Mol Physiol; 2010 May; 298(5):L616-25. PubMed ID: 20061443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette smoking aggravates bleomycin-induced experimental pulmonary fibrosis.
    Zhou LL; Wang M; Liu F; Lu YZ; Song LJ; Xiong L; Xiang F; He XL; Shuai SY; Xin JB; Ye H; Yu F; Ma WL
    Toxicol Lett; 2019 Mar; 303():1-8. PubMed ID: 30572104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.